Total and High-Molecular-Weight Adiponectin in Breast Cancer:In Vitroandin VivoStudies
Open Access
- 1 March 2007
- journal article
- other
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (3) , 1041-1048
Abstract
Background: Obesity is a major risk factor for breast cancer. We hypothesized that obesity-induced decreases in total and/or high-molecular-weight (HMW) adiponectin levels may underlie this association. Methods: We measured serum total and HMW adiponectin in a hospital-based case-control study of 74 female breast cancer patients and 76 controls. In parallel, expression of adiponectin and its receptors AdipoR1/R2 were measured in tissue samples using RT-PCR, and protein expression of AdipoR1/R2 was localized and quantified using immunohistochemistry. Finally, we documented AdipoR1/R2 expression in several breast cancer cell lines and studied adiponectin signaling and the effect of adiponectin on proliferation in the T47D breast cancer cell line in vitro. Results: Women with the highest adiponectin levels had a 65% reduced risk of breast cancer (P = 0.04). This association became stronger after adjustment for age, body mass index, and hormonal and reproductive factors (P = 0.02). Modeling HMW instead of total adiponectin produced similar results and did not offer any additional predictive value. Breast cancer cells expressed AdipoR1/R2 but not adiponectin. Expression of AdipoR1, but not AdipoR2, was higher in tumor tissue than both adjacent and control tissues. Exposure of T47D cells to adiponectin significantly inhibited the percentage of viable cells to 86% and proliferation to 66% but had no effect on apoptosis. These effects were associated with activation of ERK1/2 but not AMP-activated protein kinase or p38MAPK. Conclusion: These studies suggest that adiponectin may act as a biomarker of carcinogenesis and may constitute a molecular link between obesity and breast cancer.Keywords
This publication has 26 references indexed in Scilit:
- Adiponectin and cancer: a systematic reviewBritish Journal of Cancer, 2006
- Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to comeBest Practice & Research Clinical Endocrinology & Metabolism, 2005
- Body mass index and cancer: Results from the Northern Sweden Health and Disease CohortInternational Journal of Cancer, 2005
- Adiponectin – journey from an adipocyte secretory protein to biomarker of the metabolic syndromeJournal of Internal Medicine, 2005
- Obesity, adipocytokines, and insulin resistance in breast cancerObesity Reviews, 2004
- Adipose Tissue as an Endocrine OrganThe Journal of Clinical Endocrinology & Metabolism, 2004
- Adiponectin and Breast Cancer RiskThe Journal of Clinical Endocrinology & Metabolism, 2004
- Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosisProceedings of the National Academy of Sciences, 2004
- Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilizationOncogene, 2003
- Growth of epithelium from a preneoplastic mammary outgrowth in response to mammary adipose tissueIn Vitro Cellular & Developmental Biology, 1989